Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

STDs

Growing Antibiotic Resistance Forces WHO to Update Recommended Treatment for Sexually Transmitted Diseases

WHOGeneva, Switzerland, August 31, 2016 — New guidelines for the treatment of three common sexually transmitted infections (STIs) have been issued by the World Health Organization (WHO) in response to the growing threat of antibiotic resistance.

Chlamydia, gonorrhea and syphilis are all caused by bacteria and are generally curable with antibiotics. However, these STIs often go undiagnosed and are becoming more difficult to treat, with some antibiotics now failing as a result of misuse and overuse.

It is estimated that, each year, 131 million people are infected with chlamydia, 78 million with gonorrhea, and 5.6 million with syphilis. Continue reading